December Meeting 2009 Fellow/Resident Poster Award Winners:
Thursday, December 3rd Winners
Genevieve Nadeau (#78): Copy number of sex-steroid metabolizing genes as biomarkers of prostate cancer (Laval University)
Melanie Ketchandji (#74): Disseminated prostate cancer CTCs: best marker (UW, Seattle)
William Lowrance (#5): Comparative effectiveness of surgical treatments for PCa (MSKCC)
Friday, December 4th Winners
Danil Makarov (#109): Inappropriate imaging use for PCa staging (Yale)
E. Jason Abel (#154): Biopsy of metastatic sites of RCC (MD Anderson)
Sultan Alkhateeb (#192): Prognosis of primary or recurrent T1G3 TCC post BCG (Toronto)
December Meeting 2008 Fellow/Resident Poster Award Winners:
Thursday, December 4th Poster Session I Winners
1st. $350.00
Jay Bakul Shah, MD Anderson Cancer Center
Poster 7 – The SRC inhibitor AZD350 induces growth inhibition and migratory arrest of human bladder cancer cell lines
2nd $250.00
JoseAntonio Karam, University of Texas Southwestern Medical Center
Poster 1 – Uoprregulation of trag3 (taxol resistance associated gene3) is associated with advanced bladder cancer (BCA)
3rd $150.00
Robert Scott Svatek, MD Anderson Cancer Center
Poster 14 – The transcription repressor, ZEB1, regulates epithelial to mesenchmal transition in bladder cancer
Friday, December 5th Poster Session Winners
1st
Vitaly Margulis, MD, MD Anderson Cancer Center
Poster 187 – Multi-institutional validation of the predictive value of KI-67 labeling index patients with urinary bladder cancer
2nd
Vincent Fradet, MD, UCSF, San Francisco
Poster 103 – Dietary Omega-3 Fatty Acids, COX-2 generic variation, and aggressive prostate cancer risk
3rd
Matthew Cooperberg, MD, University of California
Poster 170 – National trends in treatment of stage irenal cell carcinoma
December Meeting 2007 Fellow/Resident Poster Award Winners:
R. Houston Thompson, MD; Memorial Sloan Kettering Cancer Center
B7-H3 AND B7X ARE HIGHLY EXPRESSED IN HUMAN PROSTATE CANCER AND ASSOCIATED WITH DISEASE SPREAD AND POOR OUTCOME
R. Houston Thompson, MD; Xingxing Zang, PhD; Hikmat Al-Ahamadie, MD; Angel Serio, MS; Victor Reuter, MD; James Eastham, MD; Peter Scardino, MD; Padmanee Sharma, MD and James Allison, PhD (Presented by: R. Houston Thompson)
Boris Hadaschick, MD; The Prostate Centre at VGH
INTRAVESICAL THERAPY OF HIGH GRADE BLADDER CANCER WITH HTI-286
Boris Hadaschik, MD; Hans Adomat; Ladan Fazli, MD; Martin Gleave, MD and Alan So, MD (Presented by: Boris Hadaschik)
Shahrokh Shariot, MD; UT Southwestern Medical School
MULTIPLE BIO-MARKERS FOR THE PREDICTION OF BLADDER CANCER RECURRENCE AND MORTALITY
Shahrokh Shariat, MD; Pierre I. Karakiewicz, MD; Raheela Ashfaq, MD; Seth P. Lerner, MD; Ganesh S. Palapattu, MD; Richard J. Cote, MD; Arthur I. Sagalowsky, MD and Yair Lotan, MD (Presented by: Shahrokh Shariat)
December Meeting 2006 Fellow/Resident Poster Award Winners:
Stephen Boorjian, MD; Mayo Clinic
THE IMPACT OF GLEASON SCORE ON THE PREDICTIVE VALUE OF PSA DOUBLING TIME
Stephen Boorjian, MD; Sameer Siddiqui, MD; Brant Inman, MD; Jeffrey Slezak; R. Jeffrey Karnes, MD; Michael Blute, MD and Bradley Leibovich, MD (Presented By: Stephen Boorjian, MD)
Ofer Yossepowitch, MD; Memorial Sloan Kettering Cancer Center
RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED HIGH-RISK PROSTATE CANCER: CRITICAL ANALYSIS OF RISK-ASSESSMENT METHODS
Ofer Yossepowitch, MD; Scott Eggener, MD; Fernando Bianco, MD; Brett Carver, MD; Angel Serio, MD; Peter Scardino, MD and James Eastham, MD (Presented By: Ofer Yossepowitch, MD)
Todd Morgan, MD; University of Washington
DETECTION AND ISOLATION OF DISSEMINATED TUMOR CELLS BY ENRICHMENT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
Todd Morgan, MD; Daniel Lin, MD; William Ellis, MD; Ian Gallaher, BA; Marty Kinnunen, BA; Bryce Lakely, BA; Paul Lange, MD and Robert Vessella, PhD (Presented By: Todd Morgan, MD)
December Meeting 2005 Fellow/Resident Poster Award Winners:
R. Houston Thompson, MD, Mayo Clinic
COMPLICATIONS FROM CONTEMPORARY OPEN NEPHRON-SPARING SURGERY
R. Houston Thompson, MD, Bradley Leibovich, MD, Christine Lohse, MS, Horst Zincke, MD PhD and Michael Blute, MD (Presented By: R. Houston Thompson, MD)
Bungo Furusato, MD, PhD, Armed Forces Institute for Pathology
GENE EXPRESSION SIGNATURES IN BENIGN AND MALIGNANT EPITHELIAL CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED (FPPE) TISSUES OF PROSTATE CANCER PATIENTS
Bungo Furusato, MD, PhD, Gyorgy Petrovics, PhD, Vasantha Srikantan, DVM, PhD, Syed Shaheduzzaman, PhD, Lakshmi Ravindranath, BS, Martin E Nau, PhD, Maryanne Vahey, PhD, David G McLeod, MD, Shiv Srivastava, PhD and Isabell A Sesterhenn, MD (Presented By: Bungo Furusato, MD, PhD)
Paul Crispen, MD, Fox Chase Cancer Center
TREATMENT WITH TNF-A AND TPEN DECREASES NF-KB ACTIVITY AND INDUCES APOPTOSIS IN PC-3 CELLS
Paul Crispen, MD, Konstantin Golovine, MD PhD, Peter Makhov, MD PhD, Alan Pollack, MD PhD, Eric Horwitz, MD, Richard Greenberg, MD, Robert Uzzo, MD and Vladimir Kolenko, MD PhD (Presented By: Paul Crispen, MD)